Immunomedics (IMMU) Issues Encouraging Update for Epratuzumab w/ 90Y on NHL
Tweet Send to a Friend
Immunomedics, Inc. (Nasdaq: IMMU) reported that adding two doses of epratuzumab labeled with the radioisotope, yttrium-90 (90Y), to a combination ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
